Suppr超能文献

非结核分枝杆菌中的耐药性:机制与模型

Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models.

作者信息

Saxena Saloni, Spaink Herman P, Forn-Cuní Gabriel

机构信息

Institute of Biology Leiden, Animal Science and Health, Leiden University, Einsteinweg 55, 2333CC Leiden, The Netherlands.

出版信息

Biology (Basel). 2021 Jan 29;10(2):96. doi: 10.3390/biology10020096.

Abstract

The genus comprises a multitude of species known to cause serious disease in humans, including and , the responsible agents for tuberculosis and leprosy, respectively. In addition, there is a worldwide spike in the number of infections caused by a mixed group of species such as the , and complexes, collectively called nontuberculous mycobacteria (NTMs). The situation is forecasted to worsen because, like tuberculosis, NTMs either naturally possess or are developing high resistance against conventional antibiotics. It is, therefore, important to implement and develop models that allow us to effectively examine the fundamental questions of NTM virulence, as well as to apply them for the discovery of new and improved therapies. This literature review will focus on the known molecular mechanisms behind drug resistance in NTM and the current models that may be used to test new effective antimicrobial therapies.

摘要

该属包含众多已知可导致人类严重疾病的物种,包括分别作为结核病和麻风病病原体的结核分枝杆菌和麻风分枝杆菌。此外,由诸如鸟分枝杆菌、胞内分枝杆菌和堪萨斯分枝杆菌复合体等一组混合物种引起的感染数量在全球范围内呈上升趋势,这些物种统称为非结核分枝杆菌(NTMs)。由于与结核病一样,非结核分枝杆菌天然具有或正在对传统抗生素产生高度耐药性,预计情况会恶化。因此,实施和开发能够让我们有效研究非结核分枝杆菌毒力基本问题的模型,并将其应用于发现新的和改进的治疗方法非常重要。这篇文献综述将聚焦于非结核分枝杆菌耐药性背后已知的分子机制以及可用于测试新的有效抗菌疗法的当前模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e7f/7911849/6086fb799933/biology-10-00096-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验